Abstract
Purpose
To evaluate the feasibility and safety of minimally invasive, percutaneous techniques in metachronous recurrent renal cell cancers (RCCs) in solitary kidneys.
Methods
In 4 patients, recurrent RCC was treated by radiofrequency ablation (RFA) (RITA, StarBurst) alone, and in 2 patients by RFA in combination with superselective transarterial particle-lipiodol embolization using 3 Fr microcatheters. RFA was guided by computed tomography in 5 patients, and by magnetic resonance imaging in 1 patient. Mean tumor diameter was 26.7 mm (range 10–45 mm). All interventions were technically successful; during follow-up 1 patient developed recurrent RCC, which was retreated by RFA after embolization.
Results
No major peri- or postprocedural complications occurred. Changes in creatinine (pre- vs. post-intervention, 122 vs. 127 μmol/l) and calculated creatinine clearance (pre- vs. post-intervention, 78 vs. 73 ml/min) after ablation were minimal.
Conclusion
In single kidneys, percutaneous, minimally invasive techniques are safe and feasible. In large tumors, or where there are adjacent critical structures, we prefer a combination of embolization and thermal ablation (RFA).
Similar content being viewed by others
References
Mitchell RE, Gilbert SM, Murphy AM, et al. (2006) Partial nephrectomy and radical nephrectomy offer similar cancer outcomes in renal cortical tumors 4 cm or larger. Urology 67:260–264
Nieder AM, Taneja SS (2003) The role of partial nephrectomy for renal cell carcinoma in contemporary practice. Urol Clin North Am 30:529–542
Mayo-Smith WW, Dupuy DE, Parikh PM, et al. (2003) Imaging-guided percutaneous radiofrequency ablation of solid renal masses: Techniques and outcomes of 38 treatment sessions in 32 consecutive patients. AJR Am J Roentgenol 180:1503–1508
Gervais DA, Arellano RS, Mueller PR (2005) Percutaneous radiofrequency ablation of renal cell carcinoma. Eur Radiol 15:960–967
Varkarakis IM, Allaf ME, Inagaki T, et al. (2005) Percutaneous radio frequency ablation of renal masses: Results at a 2-year mean followup. J Urol 174:456–460; discussion 460
Matlaga BR, Zagoria RJ, Woodruff RD, et al. (2002) Phase II trial of radio frequency ablation of renal cancer: Evaluation of the kill zone. J Urol 168:2401–2405
Gervais DA, McGovern FJ, Arellano RS, et al. (2003) Renal cell carcinoma: Clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 226:417–424
Pavlovich CP, Walther MM, Choyke PL, et al. (2002) Percutaneous radio frequency ablation of small renal tumors: Initial results. J Urol 167:10–15
Buscarini L, Buscarini E, Di Stasi M, et al. (1999) Percutaneous radiofrequency thermal ablation combined with transcatheter arterial embolization in the treatment of large hepatocellular carcinoma. Ultraschall Med 20:47–53
Yamakado K, Nakatsuka A, Akeboshi M, et al. (2004) Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival. Oncol Rep 11:105–109
Bani-Hani AH, Leibovich BC, Lohse CM, et al. (2005) Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2352 patients. J Urol 173:391–394
Henriksson C, Geterud K, Aldenborg F, et al. (1992) Bilateral asynchronous renal cell carcinoma. Computed tomography of the contralateral kidney 10–43 years after nephrectomy. Eur Urol 22:209–212
Rabbani F, Herr HW, Almahmeed T, et al (2002) Temporal change in risk of metachronous contralateral renal cell carcinoma: influence of tumor characteristics and demographic factors. J Clin Oncol 20:2370–2375
Grimaldi G, Reuter V, Russo P (1998) Bilateral non-familial renal cell carcinoma. Ann Surg Oncol 5:548–552
Park JH, Kim SH, Han JK, et al. (1994) Transcatheter arterial embolization of unresectable renal cell carcinoma with a mixture of ethanol and iodized oil. Cardiovasc Intervent Radiol 17:323–327
Omary RA, Bettmann MA, Cardella JF, et al. (2003) Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 14:S293–295
Sacks D, McClenny TE, Cardella JF, et al. (2003) Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 14:S199–202
Thomis JA, Soep HH, Hallynck T, et al. (1982) Creatinine clearance, different methods of determination. Br J Clin Pharmacol 13:260–262
Gervais DA, Arellano RS, Mueller P (2005) Percutaneous ablation of kidney tumors in nonsurgical candidates. Oncology (Williston Park) 19(11 Suppl 4):6–11
den Brok MH, Sutmuller RP, van der Voort R, et al. (2004) In situ tumor ablation creates an antigen source for the generation of antitumor immunity. Cancer Res 64:4024–4029
Goldberg SN, Gazelle GS, Mueller PR (2000) Thermal ablation therapy for focal malignancy: A unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 174:323–331
Pennes HH (1948) Analysis of tissue and arterial blood temperatures in the resting human forearm. J Appl Physiol 1:93–122
Hall WH, McGahan JP, Link DP, et al. (2000) Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor. AJR Am J Roentgenol 174:1592–1594
Tacke J, Mahnken A, Bucker A, et al. (2001) Nephron-sparing percutaneous ablation of a 5 cm renal cell carcinoma by superselective embolization and percutaneous RF-ablation. Rofo 173:980–983
Yamakado K, Nakatsuka A, Kobayashi S, et al. (2006) Radiofrequency ablation combined with renal arterial embolization for the treatment of unresectable renal cell carcinoma larger than 3.5 cm: Initial experience. Cardiovasc Intervent Radiol ??: ????
Almgard LE, Slezak P (1977) Treatment of renal adenocarcinoma by embolization: A follow-up of 38 cases. Eur Urol 3:279–281
Lalli AF, Peterson N, Bookstein JJ (1969) Roentgen-guided infarctions of kidneys and lungs: A potential therapeutic technique. Radiology 93:434–435
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gebauer, B., Werk, M., Lopez-Hänninen, E. et al. Radiofrequency Ablation in Combination with Embolization in Metachronous Recurrent Renal Cancer in Solitary Kidney after Contralateral Tumor Nephrectomy. Cardiovasc Intervent Radiol 30, 644–649 (2007). https://doi.org/10.1007/s00270-007-9012-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-007-9012-y